YOLFTbeta
Tiziana Life Sciences Ltd

Tiziana Life Sciences Ltd

TLSA · NASDAQ · Healthcare / Biotechnology

0.5699USD-0.04 (-6.65%)

Price History

Full chart

Market Stats

Previous Close0.6105
Open0.60
Day Range0.5655 – 0.6292
52-Week Range0.76 – 2.33
Volume265.50K
Market Cap124.78M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.16
Dividend Yield0.00%
Beta0.45
50-Day Avg0.9974
200-Day Avg1.27

About

Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis; and TZLS-501, a human anti-IL-6R monoclonal antibody for the treatment of autoimmune and inflammatory diseases. The company is headquartered in London, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Ivor R. Elrifi Ph.D.
  • Employees10
  • Headquarters14/15 Conduit Street, London, United Kingdom, W1S 2XJ, USA
  • Websitehttps://www.tizianalifesciences.com

Leadership

  • Mr. Gabriele Marco Antonio Cerrone M.B.A.Founder & Executive Chairman · b. 1972
  • Ms. Keeren ShahCOO & CFO · b. 1976
  • Dr. Ivor R. Elrifi Ph.D.CEO & Executive Director
  • Mr. William Edward Tente M.S.Chief Regulatory Officer · b. 1958
  • Dr. Richard K. Kim M.D.Chief Medical Officer · b. 1971
  • Dr. Napoleone Ferrara M.D.Member of Scientific Advisory Board · b. 1957

Financials

Income Statement

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue------99.00K116.00K405.00K64.00K92.00K56.00K187.34K-127.31K-3.00K000000000000
Growth (%)-------+17.17%+249.14%-84.20%+43.75%-39.13%+234.53%-167.96%---100.00%-----------
Cost of Revenue------45.00K40.00K209.00K24.00K20.00K11.00K282.05K---008.79K10.68K16.00K250.04K89.76K141.00K51.00K--234.00K
Gross Profit------54.00K76.00K196.00K40.00K72.00K45.00K-94.71K-127.31K-195.00K3.00K00-8.79K-10.68K-16.00K-250.04K-89.76K-141.00K-51.00K---234.00K
Gross Margin------54.55%65.52%48.40%62.50%78.26%80.36%-50.56%100.00%-100.00%------------
Operating Expense------1.55M2.29M2.48M2.59M1.61M799.00K2.94M321.39K263.00K257.85K2.76M12.76M7.28M8.24M9.89M9.71M38.03M36.78M17.88M--20.90M
Operating Income-272.00K-554.00K-2.35M-2.41M-2.37M-1.98M-1.50M-2.21M-2.29M-2.55M-1.54M-754.00K-3.03M-448.70K-458.00K-254.84K-2.76M-12.76M-7.29M-8.25M-9.91M-9.96M-38.12M-36.93M-17.93M-22.73M-15.79M-21.13M
Operating Margin-------1512.12%-1907.76%-564.44%-3982.81%-1675.00%-1346.43%-1617.92%352.44%--8494.83%------------
EBITDA-271.00K-553.00K-2.33M-2.39M-2.35M-1.95M-1.48M-2.18M-2.15M-2.49M-1.24M-516.00K-3.03M-448.70K-458.00K-283.00K-2.65M-12.76M-7.28M-8.23M-9.89M-9.71M-37.99M-35.53M-18.85M-21.66M-16.62M-18.18M
EBITDA Margin-------1491.92%-1879.31%-531.60%-3890.63%-1348.91%-921.43%-1617.92%352.44%--9433.33%------------
Net Income-272.00K-554.00K-2.27M-2.33M-2.31M-1.96M-1.39M-2.14M-2.18M-2.42M-1.43M-730.00K-4.68M-1.21M-848.00K-280.00K-3.51M-12.79M-7.21M-6.77M-7.98M-9.36M-35.54M-31.59M-18.92M-22.36M-11.86M-18.43M
Net Income Margin-------1402.02%-1845.69%-537.28%-3776.56%-1553.26%-1303.57%-2497.10%948.78%--9333.33%------------
R&D----580.00K326.00K457.00K745.00K826.00K737.00K412.00K80.00K----794.00K9.31M2.96M4.67M5.50M3.73M8.15M17.82M15.92M10.25M5.23M10.28M
R&D as % of Total Revenue------461.62%642.24%203.95%1151.56%447.83%142.86%----------------
Interest Expense---4.00K2.00K8.00K5.00K10.00K8.00K5.00K3.00K4.00K4.96K00014.35K26.67K9.89K8.74K11.98K93.57K435.28K237.41K8.60K12.64K6.00K18.00K
Interest Expense % of Total Revenue------5.05%8.62%1.98%7.81%3.26%7.14%2.65%0.00%-0.00%------------

Balance Sheet

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.67M2.35M4.50M3.33M2.56M3.31M4.14M3.44M3.16M2.90M1.98M1.73M1.02M625.00K96.00K126.00K2.46M9.25M5.05M1.83M6.91M1.81M70.66M48.83M26.48M12.18M11.28M11.49M
Total Liabilities419.00K366.00K493.00K363.00K359.00K282.00K601.00K618.00K732.00K462.00K641.00K517.00K416.00K100.00K136.00K272.00K683.00K746.00K1.74M3.51M6.39M5.99M8.27M7.55M6.91M6.65M7.35M11.44M
Total Equity2.25M1.99M4.01M2.96M2.21M3.03M3.54M2.83M2.43M2.44M1.34M1.21M604.00K525.00K-40.00K-146.00K1.78M8.50M3.31M-1.68M518.10K-4.18M45.71M41.28M19.57M5.54M3.94M52.00K
Cash563.00K157.00K2.18M1.10M7.00K996.00K771.00K941.00K508.00K588.00K25.00K30.00K70.25K33.00K4.00K61.00K2.27M8.90M4.70M48.00K5.29M153.00K65.82M42.19M18.12M1.18M3.72M4.01M
Total Debt----69.00K-101.00K77.00K72.00K51.00K52.00K49.00K---230.00K206.00K216.00K225.00K234.00K309.46K1.42M555.00K1.35M365.00K247.00K106.00K456.00K
Net Debt-563.00K-157.00K-2.18M-1.10M62.00K-996.00K-670.00K-864.00K-436.00K-537.00K27.00K19.00K-70.25K-33.00K-4.00K169.00K-2.06M-8.69M-4.48M186.00K-4.99M1.27M-65.27M-40.83M-17.76M-936.00K-3.62M-3.55M

Cash Flow

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-310.00K-527.00K-2.19M-2.46M-1.57M-1.52M-1.72M-1.18M-1.96M-2.15M-959.80K-535.42K-407.86K-881.91K-227.89K-97.13K-2.31M-5.70M-5.62M-5.68M-4.60M-5.29M-8.76M-16.13M-15.99M-12.42M-1.22M-12.85M
Investing Cash Flow-128.00K-271.00K-2.36M997.00K870.00K-394.00K-53.00K-112.37K-120.95K-70.75K-116.77K-41.63K-102.12K-655.49K133.18K1.92K65.62K-252.00K-276.93K-970-788.08-2.98K-93.25K96.36K-3.26M-991.57K-56.73K3.04M
Financing Cash Flow1.00M392.00K4.73M1.28M488.00K2.04M1.65M1.48M1.67M2.32M484.35K585.12K558.48K1.57M66.10K150.02K4.57M12.56M1.28M1.16M10.08M1.31M54.12M-17.05K-44.84K31.65K3.60M10.01M
Capital Expenditure128.00K271.00K313.00K131.00K80.00K50.00K71.00K11.40K12.19K711111.00K366.99K000205.90K1.69M38.46K968.61.312.98K1.89K16.31K0015.18K21.00K
Free Cash Flow-438.00K-798.00K-2.51M-2.59M-1.65M-1.57M-1.79M-1.20M-1.98M-2.15M-959.80K-535.42K-474.85K-881.91K-227.89K-97.13K-2.31M-5.70M-5.65M-5.68M-4.60M-5.29M-8.76M-16.15M-15.99M-12.42M-1.23M-12.87M
Dividends Paid----------------00000-------
FCF to OCF141.29%151.42%114.27%105.33%105.09%103.28%104.13%100.96%100.62%100.03%100.00%100.00%116.42%100.00%100.00%100.00%100.00%100.00%100.68%100.02%100.00%100.06%100.02%100.10%100.00%100.00%101.25%100.16%
Dividend Paid to FCF----------------0.00%0.00%0.00%0.00%0.00%-------

Earnings

Report DateMar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017May 31, 2017Sep 29, 2017Nov 29, 2017Mar 31, 2018Jun 30, 2018Sep 24, 2018Nov 21, 2018Mar 31, 2019Apr 4, 2019Sep 30, 2019Nov 27, 2019Mar 31, 2020Jun 17, 2020Sep 30, 2020Dec 2, 2020Mar 31, 2021May 17, 2021Sep 24, 2021Dec 1, 2021May 22, 2022Dec 27, 2022Oct 18, 2024Jun 23, 2025Oct 3, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.01-0.04-0.140.00-0.25-0.01-0.040.00-0.040.000.00-0.060.000.00-0.00
EPS Actual-0.04-0.04-0.11-0.11-0.03-0.04-0.04-0.04-0.02-0.02-0.04-0.03-0.03-0.03-0.11-0.05-0.02-0.02-0.10-0.01-0.02-0.03-0.12-0.14-0.02-0.04-0.04-0.04-0.06-0.06-0.080.00-0.06-0.06-0.05-0.07-0.05
Surprise----------------------236.00%-200.00%0.00%-84.16%-296.00%0.00%--42.68%--0.00%----
Timing-------------------After-hours-Pre-marketPre-market--After-hoursPre-market--After-hoursAfter-hours-After-hoursAfter-hours-After-hours-

Key Statistics & Ratios

Market Cap124.78M
Enterprise Value130.07M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book2569.66
EPS-0.16
Book Value0.00
Revenue (TTM)-3.60M
Gross Profit (TTM)0
EBITDA-21.12M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-924.32%
Return on Assets-115.96%
Shares Outstanding127.26M
Shares Float61.89M
Beta0.45
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
1.94%
Insiders
47.65%
Retail / Other
50.41%

Top Institutional Holders

  • Dauntless Investment Group, LLC
    2.17M1.70%
  • Mid-American Wealth Advisory Group, Inc.
    323.24K0.25%
  • Marshall Wace Asset Management Ltd
    157.57K0.12%
  • Zhang Financial LLC
    125.95K0.10%
  • UBS Group AG
    95.70K0.08%
  • Citadel Advisors Llc
    80.22K0.06%
  • The Colony Group LLC
    79.36K0.06%
  • Geode Capital Management, LLC
    78.20K0.06%
  • The Goldman Sachs Group Inc
    75.66K0.06%
  • HSBC Holdings PLC
    62.44K0.05%
  • Morgan Stanley - Brokerage Accounts
    52.16K0.04%
  • EWA, LLC
    44.69K0.04%
  • XTX Topco Ltd
    28.50K0.02%
  • Jane Street Group LLC
    24.05K0.02%
  • Private Advisor Group, LLC
    19.64K0.02%
  • China Universal Asset Mgmt Co.Ltd
    18.00K0.01%
  • Susquehanna International Group, LLP
    17.27K0.01%

Top Fund Holders

  • Goldman Sachs Absolute Ret Trckr Instl
    87.03K0.07%
  • Fidelity Nasdaq Composite Index
    86.20K0.07%
  • China Universal Gbl YLBJ QDII CNH
    18.00K0.01%

Stock Splits

  • Jul 31, 20202499:1000
  • Oct 29, 20192:1